Zynex Inc (ZYXI) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket
 


Zynex inc   (NASDAQ: ZYXI)


Zynex Inc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Zynex Inc's ROI in the third quarter of 2025?
Zynex Inc recorded a cumulative net loss of $-74 million during 12 months ending in the third quarter of 2025, resulting in a negative return on investment (ROI) of -158.6%.

Within the Healthcare sector 763 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from 3727 to 4308.

Definition and Formula of Return on Investment



Return On Investment (Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
Y / Y Investment Change TTM -55.65 % -32.39 % -19.5 % -14.83 % -7.65 %
Y / Y Net Income Change TTM - - - -37.74 % 34.22 %
Investment (TTM) in Millions -29 17 94 105 94
Return On Investment (TTM) - -37.02 % -7.47 % 2.94 % 4.59 %
ZYXI's Overall Ranking # 4308 # 3727 # 3096 # 1958 # 1416
Seq. Investment Change TTM -39.77 % -21.95 % -2.62 % -3.13 % -8.18 %
Seq. Net Income Change TTM - - - -37.94 % -20.08 %
Net Income (TTM) in Millions -74 -29 -7 3 5




Return On Investment ZYXI's Ranking
Within: No.
Industry # 169
Sector # 764
Overall # 4308

Return On Investment Statistics
High Average Low
1249.89 %
46.6 %
-333.83 %
(Dec 31 2017)   (Dec 31 2014)







Financial Statements
Zynex Inc's III. Quarter Investments $ -29 Millions ZYXI's Balance sheet
Zynex Inc's III. Quarter Income $ -43 Millions Quarterly ZYXI's Income Statement
ZYXI's Income by Division See ZYXI's Income by Division


ZYXI Annual Return On Investment (Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
Total Investments in Millions 105 118 95 110 62
Y / Y Investment Growth -11.11 % 24.11 % -13.61 % 77.9 % 169.92 %
Net Income in Millions 3 10 17 17 9
Y / Y Net Income Growth -69.24 % -42.91 % -0.32 % 88.48 % -4.4 %
Annual Return On Investment 2.85 % 8.22 % 17.87 % 15.49 % 14.62 %


Annual Roi Comment
In the fiscal year 2024 ROI decreased relative to the previous year to 2.85 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ZYXI's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ZYXI's Competitors
Subscribers only: Roi for Zynex Inc's Suppliers
Subscribers only: Return On Investment for ZYXI's Customers

Other Ratios
ZYXI's Roa ZYXI's Inventory Turnover Ratio ZYXI's Growth Rates ZYXI's Dividend Statistics
ZYXI's Profitability Ratios ZYXI's Asset Turnover Ratio ZYXI's Dividend Growth
ZYXI's Roe ZYXI's Valuation Ratios ZYXI's Financial Strength Ratios ZYXI's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI


Date modified: 2026-09-08T15:11:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.